| Website | endogastricsoluti... |
| Category | BioTech |
| Employees | |
| Founded | 2002 |
| Description | Natural Orifice Surgery |
| TOTAL | $102M |
| FUNDING TOTAL | $102M |
| Series A, 6/03 Advanced Technology Ventures MPM Capital | $5M |
| Series B, 9/04 MPM Capital Advanced Technology Ventures Foundation Medical Partners | $12M |
| Venture Round, 6/09 Advanced Technology Ventures Chicago Growth Partners De Novo Ventures Foundation Medical Partners MPM Capital | $3.75M |
| Venture Round, 7/09 | $7.5M |
| Venture Round, 10/09 Advanced Technology Ventures De Novo Ventures Foundation Medical Partners MPM Capital Oakwood Medical Investors Chicago Growth Partners | $9.5M |
| Series E, 1/10 Advanced Technology Ventures Chicago Growth Partners DeNovo Ventures Foundation Medical Partners MPM Capital Oakwood Medical Investors | $21.5M |
| Series F, 8/10 Canaan Partners Radius Ventures | $30M |
| Series F, 6/12 Advanced Technology Ventures Canaan Partners Chicago Growth Partners De Novo Ventures Foundation Medical Partners Oakwood Medical Investors Radius Ventures | $13M |
EndoGastric Solutions, Inc., a medical technology company, develops incisionless transoral procedures for the treatment of upper gastrointestinal diseases, including gastroesophageal reflux disease and other GI disorders. It designs and manufactures EsophyX for use in endoluminal, transoral tissue approximation, thickness placation, and ligation in the GI tract. Its EsophyX is also indicated for the treatment of symptomatic chronic gastroesophageal reflux disease in patients who require and respond to pharmacological therapy. The company also offers Stomaphyx, a device for Natural Orifice Surgery, as well as for use in transoral tissue approximation and ligation in the GI tract. The company markets EsophyX in Austria, Belgium, Denmark, France, Germany, Greece, Ireland, Italy, Luxembourg, Mexico, the Netherlands, South Africa, Spain, Portugal, the United Kingdom, and the United States; and Stomaphyx in the Czech Republic, Finland, Hungary, Poland, Slovenia, and Sweden. EndoGastric Solutions, Inc., formerly known as EsophyX, Inc., was founded in 2002 and is headquartered in Redmond, Washington. It has a location in Redwood City, California.